Table 3.
Mixed-effect multilevel regression to assess the relationship between age-standardized female breast cancer mortality and disability and breast cancer screening (BCS) programmes, by country-income levels (high-, middle-, low-)
| Coefficient |
95% CI |
Coefficient |
95% CI |
Coefficient |
95% CI |
|
|---|---|---|---|---|---|---|
| HICs | MICs | LICs | ||||
| Mortality | ||||||
| No country/pilot screening programmea | Reference | |||||
| Regional-wise screening programme | −7.81 | −13.39 to −2.23 | −1.49 | −5.86 to 2.88 | 3.85 | −2.48 to 10.17 |
| National-wise screening programme | −9.71 | −14.70 to −4.72 | −2.90 | −7.77 to 1.97 | −0.66 | −7.52 to 6.20 |
| Disability (DALYs) | ||||||
| No country/pilot screening programmea | Reference | |||||
| Regional-wise screening programme | −184.50 | −315.47 to −53.54 | −55.72 | −184.06 to 72.62 | 78.07 | −55.04 to 211.17 |
| National-wise screening programme | −245.12 | −362.28 to −127.96 | −53.76 | −195.55 to 88.03 | 49.58 | −94.56 to 193.73 |
Models are equally adjusted as previous tables.
95 CIs, 95% confidence intervals; DALYs, disability-adjusted life years; HICs, high-income countries; LICs, low-income countries; MICs, middle-income countries.
No country programme or existence of an opportunistic or pilot screening programme.